Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025

Core Viewpoint - Journey Medical Corporation is set to release its third quarter 2025 financial results on November 12, 2025, after U.S. financial markets close, followed by a conference call at 4:30 p.m. ET [1] Company Overview - Journey Medical Corporation is a commercial-stage pharmaceutical company focused on selling and marketing FDA-approved prescription products for dermatological conditions [4] - The company currently markets eight branded FDA-approved prescription drugs aimed at treating common skin conditions [4] - Founded by Fortress Biotech, Inc., Journey Medical is located in Scottsdale, Arizona, and is registered under the Securities Exchange Act of 1934, filing periodic reports with the SEC [4] Conference Call Details - Interested parties can listen to the conference call by dialing specific numbers for domestic and international participants, with a recommendation to join approximately 10 minutes prior to the start time [2] - A live audio webcast will be available on the company's website and will remain accessible for replay for about 30 days after the call [3]